BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 3421574)

  • 1. Distinguishing benign from malignant euadrenal masses.
    Gross MD; Shapiro B; Bouffard JA; Glazer GM; Francis IR; Wilton GP; Khafagi F; Sonda LP
    Ann Intern Med; 1988 Oct; 109(8):613-8. PubMed ID: 3421574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scintigraphy of incidentally discovered bilateral adrenal masses.
    Gross MD; Shapiro B; Francis IR; Bree RL; Korobkin M; McLeod MK; Thompson NW; Sanfield JA
    Eur J Nucl Med; 1995 Apr; 22(4):315-21. PubMed ID: 7607261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High risk of malignancy in patients with incidentally discovered adrenal masses: accuracy of adrenal imaging and image-guided fine-needle aspiration cytology.
    Lumachi F; Borsato S; Tregnaghi A; Marino F; Fassina A; Zucchetta P; Marzola MC; Cecchin D; Bui F; Iacobone M; Favia G
    Tumori; 2007; 93(3):269-74. PubMed ID: 17679462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidentally discovered adrenal masses.
    Kloos RT; Gross MD; Francis IR; Korobkin M; Shapiro B
    Endocr Rev; 1995 Aug; 16(4):460-84. PubMed ID: 8521790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
    Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
    Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
    Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy.
    Kloos RT; Gross MD; Shapiro B; Francis IR; Korobkin M; Thompson NW
    World J Surg; 1997 Jan; 21(1):36-40. PubMed ID: 8943175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
    Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
    Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic evaluation of clinically silent adrenal masses.
    Gross MD; Shapiro B; Francis IR; Glazer GM; Bree RL; Arcomano MA; Schteingart DE; McLeod MK; Sanfield JA; Thompson NW
    J Nucl Med; 1994 Jul; 35(7):1145-52. PubMed ID: 8014672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Imaging of adrenal glands].
    Hoeffel C; Tenenbaum F; Bonnin A; Richard B
    Rev Prat; 1998 Apr; 48(7):718-23. PubMed ID: 11767365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential diagnosis of space-occupying adrenal masses].
    Szolar DH; Unger B; Heinz-Peer G; Preidler K; Ranner G
    Rofo; 1999 Oct; 171(4):269-78. PubMed ID: 10598161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution of nuclear medicine to the diagnosis of silent adrenal masses].
    Rufini V; Troncone L; Daidone MS; Corsello SM; Danza FM
    Radiol Med; 1994 Mar; 87(3):319-26. PubMed ID: 8146373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of the large adrenal mass.
    Khafagi FA; Gross MD; Shapiro B; Glazer GM; Francis I; Thompson NW
    Br J Surg; 1991 Jul; 78(7):828-33. PubMed ID: 1873713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal masses in oncologic patients: functional and morphologic evaluation.
    Francis IR; Smid A; Gross MD; Shapiro B; Naylor B; Glazer GM
    Radiology; 1988 Feb; 166(2):353-6. PubMed ID: 3336710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
    Maurea S; Klain M; Mainolfi C; Ziviello M; Salvatore M
    J Nucl Med; 2001 Jun; 42(6):884-92. PubMed ID: 11390552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of the scintigraphy with iodocholesterol (I-COL) to the diagnosis and characterization of silent adrenal masses].
    Rodado Marina S; Aguirre Sánchez-Covisa M; García Vicente AM; Poblete García VM; Ruiz Solís S; Cortés Romera M; Soriano Castrejón A
    Rev Esp Med Nucl; 2004; 23(3):166-73. PubMed ID: 15153359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxtaadrenal masses.
    Nakajo M; Nakabeppu Y; Yonekura R; Iwashita S; Goto T
    Ann Nucl Med; 1993 Aug; 7(3):157-66. PubMed ID: 8217490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer.
    Ettinghausen SE; Burt ME
    J Clin Oncol; 1991 Aug; 9(8):1462-6. PubMed ID: 1649268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.